Cardiac Science (NASDAQ:DFIB)
Historical Stock Chart
From Jul 2019 to Jul 2024
Florida Department of Transportation Purchases Cardiac Science
Powerheart(R) AEDs for Safety Patrol Vehicle Fleet
Vehicles Patrolling Florida's Turnpike Now Equipped With Life-Saving Devices
IRVINE, Calif., May 26 /PRNewswire-FirstCall/ -- Cardiac Science Inc.
(NASDAQ:DFIB), a leading manufacturer of live-saving automatic public-access
defibrillators (AEDs), announced today that Florida's Turnpike Enterprise, a
division of the Florida Department of Transportation, has purchased
Powerheart(R) AEDs for deployment in the fleet of Safety Patrol trucks.
The placement of the AEDs in the Safety Patrol trucks follows recent
deployments of Cardiac Science AEDs in Florida's Turnpike service plazas and
headquarters facilities, said Richard Nelson, Director of Business Development
and Concessions Management for Florida's Turnpike Enterprise. The AEDs were
deployed in the Safety Patrol trucks this week and the drivers have received
comprehensive training in their use, Nelson added.
"These Powerheart AEDs are a valuable addition to the vehicles in our Road
Ranger program dedicated solely to patrolling the Sawgrass Expressway and
Florida's Turnpike mainline and helping motorists in need," Nelson said. "We
have worked alongside Cardiac Science to deploy their AEDs, first in our
facilities and now in the Safety Patrol vehicles, as well as with the training
of the drivers. I feel certain these automatic defibrillators will prove their
value in the near future by saving lives either out on our roadways or in our
office buildings."
Florida's Turnpike Road Ranger program and the Safety Patrol trucks are
sponsored by State Farm. The trucks patrol the Sawgrass Expressway and
Florida's Turnpike's 309-mile mainline which extends from Dade City to I-75 in
Sumter County, clear debris from the roadway and offer free roadside assistance
for stranded motorists
A press conference related to the AED deployment and other matters focused on
the safety along Florida's Turnpike system has been announced by Florida
Turnpike Enterprise and will be held at 11 a.m. Thursday, May 26 (today) at the
Turkey Lake Service Plaza in Orlando.
About Cardiac Science
Cardiac Science develops, manufactures and markets a complete line of
Powerheart(R) brand, automatic public access defibrillators (AEDs), and offers
comprehensive AED/CPR training and AED program management services that
facilitate successful deployments. The company makes the Powerheart(R)
CRM(TM), the only FDA-cleared therapeutic patient monitor that instantly and
automatically treats hospitalized cardiac patients who suffer life-threatening
heart rhythms. Cardiac Science also manufactures its AED products on a private
label basis for other leading medical companies such as Nihon Kohden (Japan),
Quinton Cardiology Systems and GE Healthcare. For more information please
visit http://www.cardiacscience.com/ or call 1.949.797.3800.
This press release includes forward-looking statements. These statements may
be identified by the use of forward-looking terminology such as "anticipate,"
"believe," "continue," "could," "estimate," "expect," "intend," "may," "might,"
"plan," "potential," "predict," "should," or "will," or the negative thereof or
other variations thereon or comparable terminology. Cardiac Science has based
these forward-looking statements on the current expectations, assumptions,
estimates and projections. While Cardiac Science believes the Florida Turnpike
Enterprise deployment to be a benefit to the citizens of the region and will
save lives, these expectations, assumptions, estimates and projections, while
reasonable, are forward-looking statements and are only predictions and involve
known and unknown risks and uncertainties, many of which are beyond our
control. Certain factors, including those discussed in Cardiac Sciences' Annual
Report on Form 10-K for the year ended December 31, 2004, under the heading
"Risk Factors," may cause the actual results, performance or achievements to
differ materially from any future results, performance or achievements
expressed or implied by these forward-looking statements. Given these risks
and uncertainties, you are cautioned not to place undue reliance on such
forward-looking statements. We do not undertake any obligation to update any
such statements or to publicly announce the results of any revisions to any
such statements to reflect future events or developments.
Contact: Matt Clawson (Investors) Michael D. Gioffredi
Len Hall (Media) Chief Marketing Officer
Allen & Caron Inc Cardiac Science, Inc.
(949) 474-4300 (949) 797-3800
DATASOURCE: Cardiac Science Inc.
CONTACT: Investors, Matt Clawson, , or Media, Len
Hall, , both of Allen & Caron Inc, +1-949-474-4300, for
Cardiac Science Inc.; or Michael D. Gioffredi, Chief Marketing Officer of
Cardiac Science, Inc., +1-949-797-3800,
Web site: http://www.cardiacscience.com/